Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for March 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Europe unaffected by GSK's manufacturing problems
No product recall needed..(more)

 Greater openness required by new European laws
MHRA clarifies position..(more)

 Renamed agency responds to pharma's strategic aims
Brader Perryman changes name..(more)

 Labour pushes ahead with 'Power to the Patient' NHS manifesto
Twin proposals unveiled..(more)

 Serono hails progress towards MS gene map
Rebif breaks $1 million mark..(more)

 New drug superior to Plavix, says Lilly
Prasugrel outperforms Plavix..(more)

 Royal Liverpool to lead paediatric medicines initiative
New research alliances promoted..(more)

 US doctors oppose black box warning for eczema drugs
Two eczema drugs get warning..(more)

 BMS hepatitis drug set for approval
First-line treatment recommended..(more)

 Avastin partners boosted by lung cancer data
Avastin results boost share prices..(more)

 Telemedicine 'disappearing from the NHS'
Research project proves point..(more)

 MRC collaborates with Pfizer on enigmatic drug targets
Pfizer matches Council's funding ..(more)

 Another reshuffle: PCTs under growing pressure to merge
Numbers could be reduced by a third..(more)

 Confusion and apathy reign as GP commissioning nears
Majority don't want to take part..(more)

 Biotech blockbusters push industry sales over $500 billion
Lipitor world number one..(more)

 Give us a break from reform, pleads NHS
Reforms coming too fast..(more)

 Diabetes patient cured in UK transplant breakthrough
Only most serious cases treated..(more)

 Pope Woodhead re-signed for Abilify account
Incumbent successful..(more)

 Potential blockbuster Tysabri pulled after patient death
Elan hopeful of return..(more)

 Heart progress trumpeted by Labour
25,000 lives saved..(more)

 Judge us on NHS record, says angry Blair
'Battle of Margaret's shoulder' goes on..(more)

 NHS Alliance warns of Health Check
Star ratings' successor critcised..(more)

 Plans for more independent prescribing progressing
Nurse prescribing exended..(more)

 Seroquel shows promise in Alzheimer's
AstraZeneca pursues licence..(more)

 SSRI guidance unchanged, says MHRA
Efexor singled out..(more)

 ABPI to oppose strictest measures in pan-European code of practice
Consensus hard to achieve..(more)

 NICE U-turn will 'set Alzheimer's treatment back 10 years'
Patient groups unhappy..(more)

 Singulair gains dual asthma-hayfever indication
Further indications planned..(more)

 Quicker service for cancer patients but 'black spots' persist
Prostate cancer a concern..(more)

 GSK rebrands AIDS drugs to foil illegal imports
Combivir and Epivir re-packaged..(more)

 NICE acts to speed lung cancer diagnosis and treatment
Cancer charity voices concerns ..(more)

 Sankyo and Daiichi set to continue Japanese consolidation
Companies follow Astellas tie-up..(more)

 Private sector involvement in NHS continues to grow
Existing service attracts complaints..(more)

 Cymbalta approved for second indication
Diabetic pain licence granted..(more)

 NHS is behind us, says rep-free Takeda
Research results vindicate decision..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.